The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for…
The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable…
On November 17, Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, participated in a…
Study goals, benefits, and other details
More than 45 partner sites across the US
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Study-specific materials and other information.
Privately and publicly funded clinical studies conducted around the world.
Medical Team sign-in page